Erlocip from Cipla contains Erlotinib
Below are some of the details of Erlotinib(generic)
Erlotinib is a first-line drug for the treatment of metastatic non-small cell lung cancer (NSCLC) which is either locally advanced or metastatic in nature. Erlotinib is indicated for patients who did not respond to at least one chemotherapy regimen. Erlotinib is also used as combined therapy with Gemcitabine as a first-line therapy for the treatment of locally-advanced, inoperable or metastatic pancreatic cancer.